Investigating inflammation's role in heart disease and diabetes
Official title: Inflammation: a Key Contributor to Heart Disease and Diabetes?
Run by University of Aarhus · NCT06752018 · Data updated 2026-11-12
This study is testing how inflammation affects heart disease and diabetes in people who are healthy compared to those who are severely obese, to see if it can help identify who might benefit from new treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Locations | 1 site (Aarhus) |
| Status | Recruiting |
| Started | January 30, 2025 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | February 3, 2025 |
| Trial ID | NCT06752018 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include men and women over 18 years old with a BMI of 35-50 kg/m2 who are scheduled for gastric bypass surgery, as well as healthy individuals with a BMI of 18.5-24.9 kg/m2.
✕Probably not a fit
Patients with active cancer, significant gastrointestinal problems, or underlying inflammatory diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the inflammatory response associated with cardiometabolic diseases, particularly focusing on obesity and type 2 diabetes. It involves two groups: healthy volunteers and severely obese patients undergoing weight-loss surgery. Participants will undergo baseline testing, provide tissue samples during surgery, and participate in follow-up assessments to track changes over time. The study seeks to develop a predictive model to identify individuals most likely to benefit from anti-inflammatory treatments, thereby supporting personalized therapeutic strategies.
Why it matters
Potential benefit: If successful, this study could lead to personalized treatments that effectively reduce inflammation and improve outcomes for patients with obesity and cardiometabolic diseases.
How similar studies have gone: Other studies have shown promise in understanding the relationship between inflammation and cardiometabolic diseases, but this specific approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals willing and able to give appropriate oral and written informed consent * Men and women over 18 years of age. * Correct body mass index (BMI) (Lean controls: 18.5-24.9 kg/m2. Obese gastric bypass patients: 35-50 kg/m2) Exclusion Criteria: * The individual does not follow instructions given in the research study. * Pregnancy. * Significant gastrointestinal problems. * Use of tobacco. * The individual consumed alcohol within two days prior to the study visit * Active cancer within 5 years. * Use of dietary supplements that impact the inflammatory resolution process (e.g., fish oils), and the person is not willing to discontinue the use of the supplements 1 week prior to the visits. * Underlying cardiometabolic disease, or medication related to such disease (e.g., blood pressure medication, insulin to treat diabetes, etc.). * Underlying inflammatory disease, or medication related to such disease. * The individual states that they have increased bleeding tendency or are using anti-coagulant (blood-thinning) medication. * For obese patients only: The individual has lost more than 8% of his/her body weight since their clinical referral for surgery or has lost more than 3% of his/her body weight in the 4 months leading up to surgery.
Where it's running
-
Steno Diabetes Center Aarhus
Aarhus, Denmark Recruiting
Study contacts
- Principal investigator: Emma Börgeson, Dr., PhD, MSc — University of Aarhus
- Study coordinator: Emma Börgeson, MSc
- Email: emma.borgeson@biomed.au.dk
- Phone: +45 9352 2984
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Rutazyme lemon fermented capsules for metabolic health in adults with obesity
This will test whether taking a Rutazyme lemon fermented capsule each night can help improve metabolic health in adults with obesity.
-
How moderate wine drinking affects healthy aging through post-meal extracellular vesicles
This test will see if a single serving of red or white wine changes circulating extracellular vesicles in healthy adults aged 35–65.
-
Pre-screening to identify adults who may be eligible for future metabolic and mental health opportunities.
This prescreening will see if adults with metabolic conditions or mental health disorders qualify for upcoming clinical opportunities by collecting health history, basic tests, and a doctor interview.
-
Integrated Traditional Chinese Medicine Program for Metabolic Syndrome
This study is testing a combined approach of Chinese herbal medicine and laser acupuncture to see if it can help people with metabolic syndrome improve their health over six months.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.